Skip to main content
logo
JW Pharmaceutical Corporation (KRX:001060)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,000
-150 (-0.65%)
Oct 30, 2026, 3:30 PM KST

JW Pharmaceutical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
820,862775,298719,376748,527684,351606,585
Revenue Growth
10.50%7.77%-3.89%9.38%12.82%10.82%
Gross Profit
388,220359,314323,498335,542287,955234,376
Operating Income
107,81787,87782,73396,63160,49030,848
Net Income
94,32257,42861,68137,00631,892-967.85
Earnings Per Share
4121.372497.202644.471554.671373.14-41.70
EPS Growth
93.88%-5.57%70.10%13.22%--

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
102,08461,34132,55194,196149,67865,666
Total Debt
71,75054,63591,726170,280209,542245,145
Net Cash (Debt)
30,3346,706-59,175-76,084-59,864-179,479
Net Cash Growth
------
Net Cash Per Share
1325.43291.61-2537.03-3196.37-2577.51-7733.47

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
134,47896,39679,39287,15756,76418,124
Capital Expenditures
-11,672-11,772-8,313-27,286-9,919-7,467
Free Cash Flow
122,80684,62571,07959,87146,84510,657
Free Cash Flow Growth
191.35%19.06%18.72%27.81%339.56%-78.97%

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
47.29%46.34%44.97%44.83%42.08%38.64%
Operating Margin
13.13%11.34%11.50%12.91%8.84%5.08%
Pretax Margin
14.05%11.46%11.46%7.33%6.63%3.38%
Profit Margin
11.49%7.41%8.57%4.94%4.66%-0.16%
FCF Margin
14.96%10.91%9.88%8.00%6.84%1.76%

Dividends
Chart
Fiscal Year
CurrentFY 2025
Period EndingOct '26 Dec '25
Dividend Per Share
650.000650.000
Dividend Per Share Growth
0%-
Dividend Yield
2.83%2.54%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.5810.199.1122.3913.16-
Forward PE
-6.186.5014.3410.4026.79
P/FCF Ratio
4.286.917.9013.848.9647.45
PS Ratio
0.640.750.781.110.610.83